UCB - Ebitda

Stock Price
237.00
Daily Change
-3.30 -1.37%
Monthly
-8.39%
Yearly
49.48%
Q2 Forecast
231.88

UCB reported EUR1.6B in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Alcon AG USD 795M 478M Mar/2026
Almirall EUR 114.07M 60.37M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 404.12M 17.08M Dec/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Orion EUR 130.4M 212.6M Mar/2026
Recordati EUR 247.15M 421K Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
UCB EUR 1.6B 570M Dec/2025
Unibail Rodamco EUR 1.02B 71.7M Dec/2024